---
figid: PMC4722749__12943_2015_482_Fig5_HTML
figlink: /pmc/articles/PMC4722749/figure/Fig5/
number: F5
caption: 'Importance of the type I IGF receptor and PI3-kinase/Akt pathway in the
  IGF-protection from anoikis. Representations of the alpha and beta integrins (cyan
  and light purple) and their activation of Akt via the focal adhesion and FAK signal
  transduction pathway (green) (a). The homo-tetrameric type I IGF receptor (IGF-IR,
  pink) has the α-chains of each receptor coloured lighter than the β-chains. The
  extracellular ligands: insulin (orange), IGF-2 (ochre) and IGF-1 (pale yellow) are
  shown. Signal transduction from the activated receptor is depicted through IRS-1
  via the PI3-kinase, PIP3, mTOR2, PDPK1 and Akt pathway (pink) or the Grb2, SOS,
  Ras, Raf, MEK1 and MEK2, ERK1 and ERK2 pathway (purple). The downward pointing grey
  arrow indicates constitutive activation of ERK1 and ERK2. The downward pointing
  metallic blue arrows indicate that a signal has been transduced from each pathway.
  The pale gold spheres represent phosphorylated moieties. The GTP on activated Ras
  is a light yellow sphere and the GDP on inactive Ras an ivory sphere. Uncleaved
  inactive caspase 3 is shown as a small bright yellow sphere and uncleaved active
  PARP as a large bright yellow sphere. Cleaved active caspase 3 and cleaved inactive
  PARP are shown as the equivalent fragmented spheres. Downward pointing larger blue
  arrows indicate that cell survival and downward pointing red arrows indicate that
  cell death ensues. Kinase inhibitors (brick red) that inhibit PI3-kinase, LY294002,
  or Akt, GSK 690693, abrogate the protective effect of IGF on cell survival of unattached
  cells (b) whereas the MEK1 and MEK2 kinase inhibitor, U0126, does not (c). Inhibition
  of the type I IGF receptor with the specific inhibitory antibody, figitumumab (brick
  red), induces anoikis in IGF-stimulated cells or in cells grown in serum (d)'
pmcid: PMC4722749
papertitle: 'Insulin-like growth factors are essential to prevent anoikis in oestrogen-responsive
  breast cancer cells: importance of the type I IGF receptor and PI3-kinase/Akt pathway.'
reftext: Brendan C. Luey, et al. Mol Cancer. 2016;15:8.
pmc_ranked_result_index: '146944'
pathway_score: 0.919476
filename: 12943_2015_482_Fig5_HTML.jpg
figtitle: Importance of the type I IGF receptor and PI3-kinase/Akt pathway in the
  IGF-protection from anoikis
year: '2016'
organisms:
- Homo sapiens
ndex: c09b1747-dea9-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4722749__12943_2015_482_Fig5_HTML.html
  '@type': Dataset
  description: 'Importance of the type I IGF receptor and PI3-kinase/Akt pathway in
    the IGF-protection from anoikis. Representations of the alpha and beta integrins
    (cyan and light purple) and their activation of Akt via the focal adhesion and
    FAK signal transduction pathway (green) (a). The homo-tetrameric type I IGF receptor
    (IGF-IR, pink) has the α-chains of each receptor coloured lighter than the β-chains.
    The extracellular ligands: insulin (orange), IGF-2 (ochre) and IGF-1 (pale yellow)
    are shown. Signal transduction from the activated receptor is depicted through
    IRS-1 via the PI3-kinase, PIP3, mTOR2, PDPK1 and Akt pathway (pink) or the Grb2,
    SOS, Ras, Raf, MEK1 and MEK2, ERK1 and ERK2 pathway (purple). The downward pointing
    grey arrow indicates constitutive activation of ERK1 and ERK2. The downward pointing
    metallic blue arrows indicate that a signal has been transduced from each pathway.
    The pale gold spheres represent phosphorylated moieties. The GTP on activated
    Ras is a light yellow sphere and the GDP on inactive Ras an ivory sphere. Uncleaved
    inactive caspase 3 is shown as a small bright yellow sphere and uncleaved active
    PARP as a large bright yellow sphere. Cleaved active caspase 3 and cleaved inactive
    PARP are shown as the equivalent fragmented spheres. Downward pointing larger
    blue arrows indicate that cell survival and downward pointing red arrows indicate
    that cell death ensues. Kinase inhibitors (brick red) that inhibit PI3-kinase,
    LY294002, or Akt, GSK 690693, abrogate the protective effect of IGF on cell survival
    of unattached cells (b) whereas the MEK1 and MEK2 kinase inhibitor, U0126, does
    not (c). Inhibition of the type I IGF receptor with the specific inhibitory antibody,
    figitumumab (brick red), induces anoikis in IGF-stimulated cells or in cells grown
    in serum (d)'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASP5
  - CASP2
  - CASP1
  - CASP4
  - PARP4
  - TIPARP
  - CASP6
  - CASP12
  - CASP3
  - IRS1
  - IRS2
  - MAPK1
  - MAPK3
  - KRAS
  - NRAS
  - PARP1
  - AKT1
  - AKT2
  - PARP3
  - PARP14
  - PARP16
  - CASP7
  - PARP11
  - PARP12
  - PARP8
  - PARP6
  - PARP2
  - AKT3
  - CASP10
  - CASP14
  - CASP9
  - CASP8
  - HRAS
  - MLST8
  - MTOR
  - SOS1
  - SOS2
  - PTK2
  - GRB2
  - IRS4
  - PDPK1
  - ARAF
  - MAP2K2
  - MAP2K1
  - MAPKAP1
  - RICTOR
  - PARP15
  - PARP10
  - TNKS
  - BRAF
  - PARP9
  - TNKS2
  - RAF1
  - LY294002 GSK90693
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP4
  entrez: '143'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TIPARP
  entrez: '25976'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: IRS-1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: IRS-1Grb2MEK1&2
  symbol: IRS2
  source: hgnc_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: ERK1&2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK1&2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP1
  entrez: '142'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP3
  entrez: '10039'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP14
  entrez: '54625'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP16
  entrez: '54956'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP11
  entrez: '57097'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP12
  entrez: '64761'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP8
  entrez: '79668'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP6
  entrez: '56965'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP2
  entrez: '10038'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: Grb2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS4
  entrez: '8471'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: PDPK1
  symbol: PDPK1
  source: hgnc_symbol
  hgnc_symbol: PDPK1
  entrez: '5170'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: MEK1&2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MEK1&2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP15
  entrez: '165631'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP10
  entrez: '84875'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS
  entrez: '8658'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP9
  entrez: '83666'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS2
  entrez: '80351'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
chemicals:
- word: LY294002 GSK90693
  source: MESH
  identifier: C085911
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC4722749__F5
redirect_from: /figures/PMC4722749__F5
figtype: Figure
---
